Premium
The effect of latanoprost on vitiligo: a preliminary comparative study
Author(s) -
Anbar Tag S.,
ElAmmawi Tarek S.,
AbdelRahman Amal T.,
Hanna Michel R.
Publication year - 2015
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/ijd.12631
Subject(s) - medicine , vitiligo , dermatology , latanoprost , placebo , ultraviolet b , surgery , ophthalmology , glaucoma , pathology , alternative medicine
Latanoprost ( LT ), a prostaglandin F 2alpha (PGF 2a ) analogue used in the treatment of glaucoma, was found to induce skin pigmentation in guinea pigs in addition to its known periocular and iridal pigmentation side effects. This study aims to evaluate the efficacy of topical LT in the induction of skin repigmentation in patients with vitiligo and to compare its potency with narrow band ultraviolet ( UV ) B ( NB ‐ UVB ). The result of their combination was also assessed. This study involved 22 patients with bilateral and symmetrical vitiligo lesions, stable for the last three months, divided into three groups: group I, to evaluate LT vs. placebo; group II , to evaluate LT vs. NB ‐ UVB ; and group III , to evaluate the effect of their combination. The response to treatment was evaluated by taking photographic records of the treated lesions with follow‐up photography every two weeks. After three months, assessment of the degree and extent of repigmentation was performed. Follow‐up assessment was done six months after termination of the trial for the persistence of pigmentation, recurrence, or development of any side effects. LT was found to be better than placebo and comparable with the NB ‐ UVB in inducing skin repigmentation. This effect was enhanced by the addition of NB ‐ UVB . LT could be a promising treatment for vitiligo, especially the periocular variant. Its effect on skin repigmentation could be enhanced by NB ‐ UVB exposure.